Mandate

Vinge advised Goldman Sachs and Nordea in relation to Thule’s listing on Nasdaq Stockholm

December 09, 2014

Vinge advised Goldman Sachs International and Nordea Bank AB (publ) – joint global coordinators and joint bookrunners – in relation to Thule Group AB’s application for listing on Nasdaq Stockholm. Thule’s principal shareholder is Nordic Capital. A prospectus was published on 13 November and the first day of trading on Nasdaq Stockholm was on 26 November. The total value of the offering amounts to SEK 2.1 billion, assuming that the over-allotment option is exercised in full.

Thule Group is a premium branded sports and outdoor company, with global leadership in the sport and cargo carriers market (e.g. bike carriers and roof racks) and is a leading company within other outdoor and bags product markets, selling its products in 136 countries, primarily through the Thule and Case Logic brands. The Company’s largest brand, Thule, is a premium brand recognized throughout the world among active consumers for products that are safe, easy-to-use and have a contemporary design. Through its Case Logic brand, the Company is well-established in many geographic locations in the bags for electronic devices market.

Vinge’s team consisted mainly of Peter Bäärnhielm, David Andersson and Sabina Börjesson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026